We are live on ! Find out more
MC

Mayo Clinic Portfolio holdings

AUM $2.9M
1-Year Est. Return 14.49%
This Fund
S&P 500
This Quarter Est. Return
+32.06%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.1M
AUM Growth
+$8.91M
Cap. Flow
+$1.24M
Cap. Flow %
1.49%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
1
Avg Time Held
2.8 quarters
Top 10 Avg Time Held
2.8 quarters
Top 20 Avg Time Held
2.8 quarters

Top Buys

Rank Stock Value
1
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$5.28M

Top Sells

Rank Stock Value
1
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$3.62M
2
EXAS icon
Exact Sciences
EXAS
+$240K
3
VYNT
Vyant Bio, Inc. Common Stock
VYNT
+$184K

Sector Composition

Rank Sector Weight
1 Healthcare 46.13%
2 Energy 45.97%
3 Miscellaneous 7.43%
4 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BSM icon
1
Black Stone Minerals
BSM
$3.18B
$38.2M 45.97%
5,719,924
– –
2019 Q4
4 quarters
ZNTL icon
2
Zentalis Pharmaceuticals
ZNTL
$229M
$18.8M 22.65%
362,459
-80,255
-18% -$3.62M
2020 Q2
2 quarters
UBX icon
3
DELISTED
Unity Biotechnology
UBX
$8.24M 9.91%
157,198
– –
2019 Q4
4 quarters
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$6.17M 7.43%
16,511
– –
2020 Q2
2 quarters
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$5.86M 7.05%
24,248
– –
2019 Q4
4 quarters
SRNE
6
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4.49M 5.41%
+657,877
New +$5.28M
2020 Q4
0 quarters
CLPT icon
7
ClearPoint Neuro
CLPT
$301M
$749K 0.9%
47,148
– –
2019 Q4
4 quarters
STEX icon
8
Streamex Corp
STEX
$52.9M
$393K 0.47%
10,089
– –
2019 Q4
4 quarters
EXAS icon
9
DELISTED
Exact Sciences
EXAS
$173K 0.21%
1,304
-1,985
-60% -$240K
2020 Q3
1 quarter
VYNT
10
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
– –
-89
Closed -$184K –

Similar funds

SWS
SYSTM Wealth Solutions Chicago, Illinois $3.29M AUM 31.67% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
JC
Jetstream Capital Brentwood, Tennessee $1.37M AUM
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

Mayo Clinic's Q4 2020 Portfolio in Review

As of Q4 2020, Mayo Clinic held 10 positions worth $83.1M, up 12% from $74.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mayo Clinic's Q4 2020 filing shows 1 new, 2 reduced and 1 closed positions. Its largest new stake was Sorrento Therapeutics, Inc.: 657,877 shares worth $4.49M. The largest sale was Zentalis Pharmaceuticals, an estimated $3.62M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 39% a quarter earlier, followed by Energy and Miscellaneous.

  • Mayo Clinic's largest Q4 2020 buy was Sorrento Therapeutics, Inc.: 657,877 shares worth $4.49M.
  • Mayo Clinic's biggest Q4 2020 reduction was Zentalis Pharmaceuticals, cutting an estimated $3.62M.
  • Mayo Clinic fully exited Vyant Bio, Inc. Common Stock in Q4 2020, selling an estimated $184K.
  • Mayo Clinic's ten largest holdings make up 100% of its $83.1M portfolio in Q4 2020.
  • Mayo Clinic opened 1 new position and closed 1 in Q4 2020.
  • Mayo Clinic's portfolio value rose 12% quarter-over-quarter to $83.1M.

Based on Mayo Clinic's 13F filing for Q4 2020, filed 11 Feb 2021.